Despite years of experience with related viruses, Shamonda virus continues to raise new questions. The virus, which primarily infects ruminants and is transmitted by biting midges, was detected in Europe for the first time in the summer of 2026. Since then, two genetic variants have been identified, and infections in horses and a human have also been reported.
Within bioveterinary research, we are investigating how the virus spreads and assessing the potential risks to animal and public health.
Following its first detection in Europe in the summer of 2026, the Shamonda virus (SHAV) spread rapidly. Two genetic variants have now been identified: EU-1 and EU-2.
In addition to reduced milk production, diarrhoea and fever in cattle, neurological symptoms have been reported in horses. The virus was also detected in a deceased patient with severe underlying health conditions in France. Further surveillance and research are needed to better understand the risks to animal and public health.
SHAV mainly detected in cattle
Shamonda virus (SHAV) is transmitted by biting midges and belongs to the orthobunyaviruses within the Simbu serogroup. The virus was first isolated from cattle in Nigeria in 1965 and has since been detected in both cattle and small ruminants in various regions of Africa, Asia, and now also Europe.
Strong scientific foundation for research
SHAV is closely related to the Schmallenberg virus, which caused widespread outbreaks in Europe in 2011, and the Shuni virus, which occurs in southern Africa and has also been detected in Israel in recent years.
Wageningen Bioveterinary Research (WBVR) has extensive experience in studying both viruses. This expertise provides a strong scientific foundation for investigating the introduction, spread and potential consequences of SHAV in Europe.
Transmission dynamics
The virus is thought to be transmitted by Culicoides biting midges, which were exceptionally active during the past summer. In animals, infection can cause fever, diarrhoea, reduced milk production and reproductive disorders, including abortion and congenital abnormalities in offspring.
Neurological symptoms have also been reported in horses. However, the precise epidemiology, transmission dynamics and clinical impact of SHAV are not yet fully understood. Further research and surveillance remain essential.
Potentially zoonotic
For many years, SHAV was considered exclusively an animal pathogen. However, in October 2026, the virus attracted international attention following the first reported human infection in France, involving a patient with fatal encephalitis. The patient had severe underlying health conditions.
SHAV RNA was also detected in buffalo milk in Italy, suggesting a possible alternative source of infection. Although these findings are not entirely unexpected, they highlight the potential for animal viruses to cross species barriers and pose new risks to public health.
There are currently no vaccines or specific treatments available for SHAV. However, knowledge gained from research into related viruses, such as Schmallenberg and Shuni viruses, provides WBVR researchers with a solid foundation for rapidly assessing the characteristics of SHAV, its transmission dynamics and the potential risks to animal and public health.
Frequently asked questions
Which animals are susceptible to the virus?
Shamonda virus is mainly found in ruminants, including cattle, sheep and goats. Infections and clinical symptoms have also been reported in horses. Further research is needed to determine which other animal species may be susceptible.
Is Shamonda virus dangerous to humans?
It is not yet clear what risks Shamonda virus poses to human health. In October 2026, the first human infection was reported in France in a patient with severe underlying health conditions who died from encephalitis. This finding shows that the virus can also infect humans. Further research is needed to understand how the virus is transmitted to humans and what health risks it may pose.
What is the current focus of the research at WUR?
Research within the bioveterinary research domain focuses on the spread of SHAV in Europe, the genetic differences between the EU-1 and EU-2 variants, the role of biting midges in transmission, and the consequences of infection for animals and potentially humans.
Researchers are also investigating the immune response to the virus, including the role of antibodies. Advanced cell models are being used to study the ability of SHAV to infect different host species.
This knowledge is essential for reliable risk assessment and the development of future prevention and control measures.
Should livestock farmers be concerned?
Although much remains unknown about Shamonda virus, the reported effects on milk production, fertility and animal health could have economic consequences. Early detection, surveillance and reporting of suspected clinical signs are therefore important to better understand and manage the impact of the virus.